Treatment of neonatal seizures

Seminars in Fetal and Neonatal Medicine

Volumn 18, Issue 4, 2013, Pages 209-215

  van Rooij, Linda G M ^a   Hellström Westas, Lena ^b   De Vries, Linda S ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Antiepileptic drugs; Neonatal seizures; Treatment

Indexed keywords

CLONAZEPAM; ETIRACETAM; FOSPHENYTOIN SODIUM; LIDOCAINE; LORAZEPAM; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE;

ANTICONVULSANT THERAPY; BAYLEY SCALES OF INFANT DEVELOPMENT; BRAIN INJURY; COMPARATIVE STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; HUMAN; HYPOTHERMIA; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INCIDENCE; INDUCED HYPOTHERMIA; INFANTILE SPASM; INJURY SEVERITY; LONG TERM CARE; NEUROPROTECTION; NEWBORN INTENSIVE CARE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PREMATURITY; PROTON NUCLEAR MAGNETIC RESONANCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

ANTIEPILEPTIC DRUGS; NEONATAL SEIZURES; TREATMENT;

ANIMALS; ANTICONVULSANTS; BRAIN; CHILD DEVELOPMENT; DRUG RESISTANCE; EPILEPSY; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LIDOCAINE; MIDAZOLAM; NEUROGENESIS; NEURONS; NEUROPROTECTIVE AGENTS; PHENOBARBITAL; PREMATURE BIRTH; SEIZURES; SEVERITY OF ILLNESS INDEX;

EID: 84880642347     PISSN: 1744165X     EISSN: 18780946     Source Type: Journal    
DOI: 10.1016/j.siny.2013.01.001     Document Type: Review

References (71)

1. Volpe J.J. Neurology of the newborn 2008, Saunders Elsevier, Philadelphia. 5th ed.
2. Ronen G.M., Penney S., Andrews W. The epidemiology of clinical neonatal seizures in Newfoundland: a population-based study. JPediatr 1999, 134:71-75.
3. Hoffmann G.F., Schmitt B., Windfuhr M., et al. Pyridoxal 5'-phosphate may be curative in early-onset epileptic encephalopathy. JInherit Metab Dis 2007, 30:96-99.
4. Schmitt B., Baumgartner M., Mills P.B., et al. Seizures and paroxysmal events: symptoms pointing to the diagnosis of pyridoxine-dependent epilepsy and pyridoxine phosphate oxidase deficiency. Dev Med Child Neurol 2010, 52:e133-e142.
5. Lanska M.J., Lanska D.J., Baumann R.J., Kryscio R.J. Apopulation-based study of neonatal seizures in Fayette County, Kentucky. Neurology 1995, 45:724-732.
6. Saliba R.M., Annegers F.J., Waller D.K., Tyson J.E., Mizrahi E.M. Risk factors for neonatal seizures: a population-based study, Harris County, Texas, 1992-1994. Am J Epidemiol 2001, 154:14-20.
7. Clancy R.R., Legido A., Lewis D. Occult neonatal seizures. Epilepsia 1988, 29:256-261.
8. Scher M.S., Alvin J., Gaus L., Minnigh B., Painter M.J. Uncoupling of EEG-clinical neonatal seizures after antiepileptic drug use. Pediatr Neurol 2003, 28:277-280.
9. Boylan G., Burgoyne L., Moore C., O'Flaherty B., Rennie J. An international survey of EEG use in the neonatal intensive care unit. Acta Paediatr 2010, 99:1150-1155.
10. Shellhaas R.A., Barks A.K. Impact of amplitude-integrated electroencephalograms on clinical care for neonates with seizures. Pediatr Neurol 2012, 46:32-35.
11. Boylan G.B., Rennie J.M., Pressler R.M., Wilson G., Morton M., Binnie C.D. Phenobarbitone, neonatal seizures, and video-EEG. Arch Dis Child Fetal Neonatal Ed 2002, 86:F165-F170.
12. Mizrahi E.M., Kellaway P. Characterization and classification of neonatal seizures. Neurology 1987, 37:1837-1844.
13. Silverstein F.S., Ferriero D.M. Off-label use of antiepileptic drugs for the treatment of neonatal seizures. Pediatr Neurol 2008, 39:77-79.
14. Levene M. The clinical conundrum of neonatal seizures. Arch Dis Child Fetal Neonatal Ed 2002, 86:F75-F77.
15. Miller S.P., Weiss J., Barnwell A., et al. Seizure-associated brain injury in term newborns with perinatal asphyxia. Neurology 2002, 58:542-548.
16. Lawrence R., Mathur A., Nguyen The Tich S., Zempel J., Inder T. Apilot study of continuous limited-channel aEEG in term infants with encephalopathy. JPediatr 2009, 154:835-841.
17. Shearer P., Riviello J. Generalized convulsive status epilepticus in adults and children: treatment guidelines and protocols. Emerg Med Clin North Am 2011, 29:51-64.
18. van Rooij L.G., Toet M.C., van Huffelen A.C., et al. Effect of treatment of subclinical neonatal seizures detected with aEEG: randomized, controlled trial. Pediatrics 2010, 125:e358-e366.
19. Guillet R., Edwards A.D., Thoresen M., et al. Seven- to eight-year follow-up of the CoolCap trial of head cooling for neonatal encephalopathy. Pediatr Res 2012, 71:205-209.
20. Shankaran S., Pappas A., McDonald S.A., et al. Childhood outcomes after hypothermia for neonatal encephalopathy. NEngl J Med 2012, 366:2085-2092.
21. Wusthoff C.J., Dlugos D.J., Gutierrez-Colina A., et al. Electrographic seizures during therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy. JChild Neurol 2011, 26:724-728.
22. Glass H.C., Nash K.B., Bonifacio S.L., et al. Seizures and magnetic resonance imaging-detected brain injury in newborns cooled for hypoxic-ischemic encephalopathy. JPediatr 2011, 159:731-735.
23. Low E., Boylan G.B., Mathieson S.R., et al. Cooling and seizure burden in term neonates: an observational study. Arch Dis Child Fetal Neonatal Ed 2012, 97:F267-F272.
24. Glass H.C., Kan J., Bonifacio S.L., Ferriero D.M. Neonatal seizures: treatment practices among term and preterm infants. Pediatr Neurol 2012, 46:111-115.
25. Booth D., Evans D.J. Anticonvulsants for neonates with seizures. Cochrane Database Syst Rev 2004, (4):CD004218.
26. Evans D.J., Levene M.I., Tsakmakis M. Anticonvulsants for preventing mortality and morbidity in full term newborns with perinatal asphyxia. Cochrane Database Syst Rev 2007, (3):CD001240.
27. Bittigau P., Sifringer M., Genz K., et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci USA 2002, 99:15089-15094.
28. Painter M.J., Scher M.S., Stein A.D., et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. NEngl J Med 1999, 341:485-489.
29. Bittigau P., Sifringer M., Ikonomidou C. Antiepileptic drugs and apoptosis in the developing brain. Ann NY Acad Sci 2003, 993:103-114.
30. Ikonomidou C., Bittigau P., Koch C., et al. Neurotransmitters and apoptosis in the developing brain. Biochem Pharmacol 2001, 62:401-405.
31. Bartha A.I., Shen J., Katz K.H., et al. Neonatal seizures: multicenter variability in current treatment practices. Pediatr Neurol 2007, 37:85-90.
32. Carmo K.B., Barr P. Drug treatment of neonatal seizures by neonatologists and paediatric neurologists. JPaediatr Child Health 2005, 41:313-316.
33. Clancy R.R. Summary proceedings from the neurology group on neonatal seizures. Pediatrics 2006, 117(3 Pt 2):S23-S27.
34. Glier C., Dzietko M., Bittigau P., Jarosz B., Korobowicz E., Ikonomidou C. Therapeutic doses of topiramate are not toxic to the developing rat brain. Exp Neurol 2004, 187:403-409.
35. Gilman J.T., Gal P., Duchowny M.S., Weaver R.L., Ransom J.L. Rapid sequential phenobarbital treatment of neonatal seizures. Pediatrics 1989, 83:674-678.
36. Painter M.J., Pippenger C., MacDonald H., Pitlick W. Phenobarbital and diphenylhydantoin levels in neonates with seizures. JPediatr 1978, 92:315-319.
37. Van Orman C.B., Darwish H.Z. Efficacy of phenobarbital in neonatal seizures. Can J Neurol Sci 1985, 12:95-99.
38. Castro C., Hernandez Borges A.A., Domenech M.E., Gonzalez C.C., Perera S.R. Midazolam in neonatal seizures with no response to phenobarbital. Neurology 2005, 64:876-879.
39. Boylan G.B., Rennie J.M., Chorley G., et al. Second-line anticonvulsant treatment of neonatal seizures: a video-EEG monitoring study. Neurology 2004, 62:486-488.
40. Barks J.D., Liu Y.Q., Shangguan Y., Silverstein F.S. Phenobarbital augments hypothermic neuroprotection. Pediatr Res 2010, 67:532-537.
41. Van den Broek M.P., Groenendaal F., Toet M.C., et al. Pharmacokinetics and clinical efficacy of phenobarbital in asphyxiated newborns treated with hypothermia: a thermopharmacological approach. Clin Pharmacokinet 2012, 51:671-679.
42. Meyn D.F., Ness J., Ambalavanan N., Carlo W.A. Prophylactic phenobarbital and whole-body cooling for neonatal hypoxic-ischemic encephalopathy. JPediatr 2010, 157:334-336.
43. Sarkar S., Barks J.D., Bapuraj J.R., et al. Does phenobarbital improve the effectiveness of therapeutic hypothermia in infants with hypoxic-ischemic encephalopathy?. JPerinatol 2012, 32:15-20.
44. Shany E., Benzaqen O., Watemberg N. Comparison of continuous drip of midazolam or lidocaine in the treatment of intractable neonatal seizures. JChild Neurol 2007, 22:255-259.
45. Yamamoto H., Aihara M., Niijima S., Yamanouchi H. Treatments with midazolam and lidocaine for status epilepticus in neonates. Brain Dev 2007, 29:559-564.
46. Sirsi D., Nangia S., LaMothe J., Kosofsky B.E., Solomon G.E. Successful management of refractory neonatal seizures with midazolam. JChild Neurol 2008, 23:706-709.
47. Hellstrom-Westas L., Svenningsen N.W., Westgren U., Rosen I., Lagerstrom P.O. Lidocaine for treatment of severe seizures in newborn infants. II. Blood concentrations of lidocaine and metabolites during intravenous infusion. Acta Paediatr 1992, 81:35-39.
48. Malingre M.M., van Rooij L.G., Rademaker C.M., et al. Development of an optimal lidocaine infusion strategy for neonatal seizures. Eur J Pediatr 2006, 165:598-604.
49. Radvanyi-Bouvet M.F., Torricelli A., Rey E., Bavoux F., Walti H. Effects of lidocaine on seizures in the neonatal period: some electro-clinical aspects. Neonatal seizures 1990, 275-283. Raven Press, New York. C.G. Wasterlain, P. Vert (Eds.).
50. Rey E., Radvanyi-Bouvet M.F., Bodiou C., et al. Intravenous lidocaine in the treatment of convulsions in the neonatal period: monitoring plasma levels. Ther Drug Monit 1990, 12:316-320.
51. Vento M., de Vries L.S., Alberola A., et al. Approach to seizures in the neonatal period: a European perspective. Acta Paediatr 2010, 99:497-501.
52. van Rooij L.G., Toet M.C., Rademaker K.M., Groenendaal F., de Vries L.S. Cardiac arrhythmias in neonates receiving lidocaine as anticonvulsive treatment. Eur J Pediatr 2004, 163:637-641.
53. Van den Broek M.P., Huitema A.D., van Hasselt J.G., et al. Lidocaine (lignocaine) dosing regimen based upon a population pharmacokinetic model for preterm and term neonates with seizures. Clin Pharmacokinet 2011, 50:461-469.
54. Van den Broek M.P., Groenendaal F., Egberts A.C., Rademaker C.M. Effects of hypothermia on pharmacokinetics and pharmacodynamics: a systematic review of preclinical and clinical studies. Clin Pharmacokinet 2010, 49:277-294.
55. Khan O., Chang E., Cipriani C., Wright C., Crisp E., Kirmani B. Use of intravenous levetiracetam for management of acute seizures in neonates. Pediatr Neurol 2011, 44:265-269.
56. Krief P., Li K., Maytal J. Efficacy of levetiracetam in children with epilepsy younger than 2 years of age. JChild Neurol 2008, 23:582-584.
57. Ramantani G., Ikonomidou C., Walter B., Rating D., Dinger J. Levetiracetam: safety and efficacy in neonatal seizures. Eur J Paediatr Neurol 2011, 15:1-7.
58. Brunquell P.J., Glennon C.M., DiMario F.J., Lerer T., Eisenfeld L. Prediction of outcome based on clinical seizure type in newborn infants. JPediatr 2002, 140:707-712.
59. Liu Z., Yang Y., Silveira D.C., et al. Consequences of recurrent seizures during early brain development. Neuroscience 1999, 92:1443-1454.
60. McBride M.C., Laroia N., Guillet R. Electrographic seizures in neonates correlate with poor neurodevelopmental outcome. Neurology 2000, 55:506-513.
61. Clancy R.R., Legido A. Postnatal epilepsy after EEG-confirmed neonatal seizures. Epilepsia 1991, 32:69-76.
62. Hellstrom-Westas L., Blennow G., Lindroth M., Rosen I., Svenningsen N.W. Low risk of seizure recurrence after early withdrawal of antiepileptic treatment in the neonatal period. Arch Dis Child Fetal Neonatal Ed 1995, 72:F97-F101.
63. Toet M.C., Groenendaal F., Osredkar D., van Huffelen A.C., de Vries L.S. Postneonatal epilepsy following amplitude-integrated EEG-detected neonatal seizures. Pediatr Neurol 2005, 32:241-247.
64. Ronen G.M., Buckley D., Penney S., Streiner D.L. Long-term prognosis in children with neonatal seizures: a population-based study. Neurology 2007, 69:1816-1822.
65. Glass H.C., Glidden D., Jeremy R.J., Barkovich A.J., Ferriero D.M., Miller S.P. Clinical neonatal seizures are independently associated with outcome in infants at risk for hypoxic-ischemic brain injury. JPediatr 2009, 155:318-323.
66. Bassan H., Bental Y., Shany E., et al. Neonatal seizures: dilemmas in workup and management. Pediatr Neurol 2008, 38:415-421.
67. Glass H.C., Sullivan J.E. Neonatal seizures. Curr Treat Options Neurol 2009, 11:405-413.
68. Davis A.S., Hintz S.R., Van Meurs K.P., et al. Seizures in extremely low birth weight infants are associated with adverse outcome. JPediatr 2010, 157:720-725.
69. Greisen G., Hellstrom-Westas L., Lou H., Rosen I., Svenningsen N.W. EEG depression and germinal layer haemorrhage in the newborn. Acta Paediatr Scand 1987, 76:519-525.
70. Shah D.K., Zempel J., Barton T., Lukas K., Inder T.E. Electrographic seizures in preterm infants during the first week of life are associated with cerebral injury. Pediatr Res 2010, 67:102-106.
71. Wikstrom S., Ley D., Hansen-Pupp I., Rosen I., Hellstrom-Westas L. Early amplitude-integrated EEG correlates with cord TNF-alpha and brain injury in very preterm infants. Acta Paediatr 2008, 97:915-919.